mek inhibitor Search Results


drug formulations mek inhibitors  (MedChemExpress)
95
MedChemExpress drug formulations mek inhibitors
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Drug Formulations Mek Inhibitors, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/drug formulations mek inhibitors/product/MedChemExpress
Average 95 stars, based on 1 article reviews
drug formulations mek inhibitors - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
m mek inhibitor pd0325901  (TargetMol)
92
TargetMol m mek inhibitor pd0325901
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
M Mek Inhibitor Pd0325901, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m mek inhibitor pd0325901/product/TargetMol
Average 92 stars, based on 1 article reviews
m mek inhibitor pd0325901 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
mek inhibitor  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology mek inhibitor
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek inhibitor/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mek inhibitor - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
gdc 0623  (MedChemExpress)
93
MedChemExpress gdc 0623
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Gdc 0623, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gdc 0623/product/MedChemExpress
Average 93 stars, based on 1 article reviews
gdc 0623 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
pd0325901  (ReproCELL)
95
ReproCELL pd0325901
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Pd0325901, supplied by ReproCELL, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd0325901/product/ReproCELL
Average 95 stars, based on 1 article reviews
pd0325901 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
mek inhibitor  (BOC Sciences)
90
BOC Sciences mek inhibitor
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek Inhibitor, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek inhibitor/product/BOC Sciences
Average 90 stars, based on 1 article reviews
mek inhibitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mek erk1 2 inhibitor  (Santa Cruz Biotechnology)
85
Santa Cruz Biotechnology mek erk1 2 inhibitor
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek Erk1 2 Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek erk1 2 inhibitor/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
mek erk1 2 inhibitor - by Bioz Stars, 2026-03
85/100 stars
  Buy from Supplier
mek/erk inhibitor uo216  (Promega)
90
Promega mek/erk inhibitor uo216
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek/Erk Inhibitor Uo216, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek/erk inhibitor uo216/product/Promega
Average 90 stars, based on 1 article reviews
mek/erk inhibitor uo216 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mek1 inhibitor pd184352  (Axon Medchem LLC)
90
Axon Medchem LLC mek1 inhibitor pd184352
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek1 Inhibitor Pd184352, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek1 inhibitor pd184352/product/Axon Medchem LLC
Average 90 stars, based on 1 article reviews
mek1 inhibitor pd184352 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mek inhibitor u0126  (Blackwell Science Ltd)
90
Blackwell Science Ltd mek inhibitor u0126
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Mek Inhibitor U0126, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek inhibitor u0126/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
mek inhibitor u0126 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
erk inhibitor pd98059  (Funakoshi ltd)
90
Funakoshi ltd erk inhibitor pd98059
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Erk Inhibitor Pd98059, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erk inhibitor pd98059/product/Funakoshi ltd
Average 90 stars, based on 1 article reviews
erk inhibitor pd98059 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
azd6244/arry-142886  (Array BioPharma)
90
Array BioPharma azd6244/arry-142886
<t>MEK</t> <t>inhibitors</t> reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).
Azd6244/Arry 142886, supplied by Array BioPharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/azd6244/arry-142886/product/Array BioPharma
Average 90 stars, based on 1 article reviews
azd6244/arry-142886 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


MEK inhibitors reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).

Journal: Neuro-Oncology

Article Title: Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

doi: 10.1093/neuonc/noz002

Figure Lengend Snippet: MEK inhibitors reduce MD-MSC and MD-HSC viability. Screen of 6 MEK inhibitors against (A) mouse and (B) human WT and MD-SC lines treated for 48–72 h. Mean viability is plotted with IC50 values (n = 1–3 independent experiments; 8 replicates each).

Article Snippet: 29 , 30 Drug Formulations MEK inhibitors were purchased from MedChemExpress.

Techniques:

MEK inhibitors promote G1 arrest and caspase-dependent apoptosis of MD-MSC in vitro. pERK1/2, pMEK1/2, cyclin D1, p27, and caspase-3 western blots of MD-MSC treated as indicated for (A) 5 h and (B-D) 24 h. All western blots are representative of 3–5 independent experiments. (E) Quantitation of membrane asymmetry assay of MD-MSC treated for 20 h with MEK inhibitors. Staurosporine (0.1 µM) served as a positive control for apoptosis (n = 3 independent experiments, 2-way ANOVA, *P < 0.05).

Journal: Neuro-Oncology

Article Title: Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

doi: 10.1093/neuonc/noz002

Figure Lengend Snippet: MEK inhibitors promote G1 arrest and caspase-dependent apoptosis of MD-MSC in vitro. pERK1/2, pMEK1/2, cyclin D1, p27, and caspase-3 western blots of MD-MSC treated as indicated for (A) 5 h and (B-D) 24 h. All western blots are representative of 3–5 independent experiments. (E) Quantitation of membrane asymmetry assay of MD-MSC treated for 20 h with MEK inhibitors. Staurosporine (0.1 µM) served as a positive control for apoptosis (n = 3 independent experiments, 2-way ANOVA, *P < 0.05).

Article Snippet: 29 , 30 Drug Formulations MEK inhibitors were purchased from MedChemExpress.

Techniques: In Vitro, Western Blot, Quantitation Assay, Membrane, Positive Control

MEK inhibitors slow MD-MSC growth in NSG mice. (A) Pharmacokinetic analysis for plasma and nerve following a single drug dose. (B) Representative bioluminescent (BL) images for indicated times. (C) Median tumor weights after 14 days of drug treatment compared with vehicle (n = 6–35 mice, nonparametric ANOVA). (D) BL signals were normalized to day 0 for each mouse and fold change in flux (photons/sec) after 14 days of treatment is shown (nonparametric ANOVA, median values shown). (E) Representative graft immunohistochemistry images for pERK1/2, Ki-67, cyclin D1, cleaved caspase 3, and CD31.

Journal: Neuro-Oncology

Article Title: Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

doi: 10.1093/neuonc/noz002

Figure Lengend Snippet: MEK inhibitors slow MD-MSC growth in NSG mice. (A) Pharmacokinetic analysis for plasma and nerve following a single drug dose. (B) Representative bioluminescent (BL) images for indicated times. (C) Median tumor weights after 14 days of drug treatment compared with vehicle (n = 6–35 mice, nonparametric ANOVA). (D) BL signals were normalized to day 0 for each mouse and fold change in flux (photons/sec) after 14 days of treatment is shown (nonparametric ANOVA, median values shown). (E) Representative graft immunohistochemistry images for pERK1/2, Ki-67, cyclin D1, cleaved caspase 3, and CD31.

Article Snippet: 29 , 30 Drug Formulations MEK inhibitors were purchased from MedChemExpress.

Techniques: Immunohistochemistry

MEK inhibitors reduce viability of a subset of primary human VS cells. (A) Immunohistochemistry shows S100 positivity and variable expression levels of MEK, pMEK, and pERK (green) in VS tumors (4′,6′-diamidino-2-phenylindole nuclear stain, blue). (B) Western blots demonstrate expression of MEK and pMEK for VS with beta-actin as the standard. Relative expression levels of MEK and pMEK were displayed and expressed as a ratio of pMEK/MEK. (C–D) Cell viability assays for PD0325901 and trametinib were performed and viability was normalized to 0.5% DMSO controls.

Journal: Neuro-Oncology

Article Title: Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

doi: 10.1093/neuonc/noz002

Figure Lengend Snippet: MEK inhibitors reduce viability of a subset of primary human VS cells. (A) Immunohistochemistry shows S100 positivity and variable expression levels of MEK, pMEK, and pERK (green) in VS tumors (4′,6′-diamidino-2-phenylindole nuclear stain, blue). (B) Western blots demonstrate expression of MEK and pMEK for VS with beta-actin as the standard. Relative expression levels of MEK and pMEK were displayed and expressed as a ratio of pMEK/MEK. (C–D) Cell viability assays for PD0325901 and trametinib were performed and viability was normalized to 0.5% DMSO controls.

Article Snippet: 29 , 30 Drug Formulations MEK inhibitors were purchased from MedChemExpress.

Techniques: Immunohistochemistry, Expressing, Staining, Western Blot